Irene Otero

414 total citations
14 papers, 199 citations indexed

About

Irene Otero is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Irene Otero has authored 14 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Irene Otero's work include Cancer, Hypoxia, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Irene Otero is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Irene Otero collaborates with scholars based in Spain, United States and Saudi Arabia. Irene Otero's co-authors include Alberto Carretero-González, Lucía Carril-Ajuria, Guillermo de Velasco, Luís Manso, Mike Lange, Eddie Wehri, Julia Schaletzky, Kirandeep K. Deol, James A. Olzmann and Jeremiah D. Momper and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Irene Otero

14 papers receiving 197 citations

Peers

Irene Otero

PRM

ONCOL

IMMUN

Christina Möller‐Koop Germany

Kepa Amillano Spain

David T. Hoang United States

Yuxi Ma China

Marta Román Spain

Alexandre Perrier France

I. Figueiredo United Kingdom

May Elbanna United States

Juntaro Yamasaki Japan

Jiaoyang Ning China

Christina Möller‐Koop Germany

Irene Otero

111 ×1.0

72 ×0.8

PRM

64 ×0.7

49 ×0.8

ONCOL

23 ×1.5

IMMUN

Citations per year, relative to Irene Otero Irene Otero (= 1×) peers Christina Möller‐Koop

Countries citing papers authored by Irene Otero

Since Specialization

Citations

This map shows the geographic impact of Irene Otero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Otero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Otero more than expected).

Fields of papers citing papers by Irene Otero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Otero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Otero. The network helps show where Irene Otero may publish in the future.

Co-authorship network of co-authors of Irene Otero

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Otero. A scholar is included among the top collaborators of Irene Otero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Otero. Irene Otero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Aldaz, Paula, Irene Otero, Karina Ausín, et al.. (2024). Drug-Induced Reorganisation of Lipid Metabolism Limits the Therapeutic Efficacy of Ponatinib in Glioma Stem Cells. Pharmaceutics. 16(6). 728–728. 2 indexed citations

Hendricks, Joseph M., Eddie Wehri, Zhipeng Li, et al.. (2023). Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell chemical biology. 30(9). 1090–1103.e7. 65 indexed citations

Otero, Irene, Haritz Moreno, Paula Aldaz, et al.. (2022). The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. Journal of Investigative Dermatology. 143(2). 305–316.e5. 17 indexed citations

Otero, Irene, et al.. (2021). Nivolumab induced immune mediated transverse myelitis in a patient with metastatic melanoma: The broad clinical spectrum of immune mediated neurologic disorders. SHILAP Revista de lepidopterología. 4. 100076–100076. 3 indexed citations

Carretero-González, Alberto, Irene Otero, David Lora, et al.. (2021). Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.. OncoImmunology. 10(1). 1878599–1878599. 9 indexed citations

Rowling, Emily J., Zsofia Miskolczi, Raghavendar T. Nagaraju, et al.. (2020). Cooperative behaviour and phenotype plasticity evolve during melanoma progression. Pigment Cell & Melanoma Research. 33(5). 695–708. 13 indexed citations

Carretero-González, Alberto, David Lora, Ismael Ghanem, et al.. (2019). Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials. Oncotarget. 10(35). 3294–3301. 8 indexed citations

Martín‐Broto, Javier, Nadia Hindi, Giovanni Grignani, et al.. (2019). IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II- soft-tissue sarcoma cohort. Annals of Oncology. 30. v684–v684. 11 indexed citations

Agulló-Ortuño, M. Teresa, et al.. (2019). Abstract 4854: A translational multiplexed hypothesis generating study on circulating cytokines in patients with cancer cachexia. Cancer Research. 79(13_Supplement). 4854–4854. 2 indexed citations

10.

Carretero-González, Alberto, Irene Otero, Lucía Carril-Ajuria, Guillermo de Velasco, & Luís Manso. (2018). Exosomes: Definition, Role in Tumor Development and Clinical Implications. Cancer Microenvironment. 11(1). 13–21. 38 indexed citations

11.

Martín‐Broto, Javier, Nadia Hindi, Andrés Redondo, et al.. (2018). IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) Sarcoma Groups phase I/II trial of sunitinib plus nivolumab in selected bone and soft tissue sarcoma subtypes—Results of the phase I part.. Journal of Clinical Oncology. 36(15_suppl). 11515–11515. 10 indexed citations

12.

Velasco, Guillermo de, Lucía Trilla‐Fuertes, Angelo Gámez‐Pozo, et al.. (2017). Urothelial cancer proteomics provides both prognostic and functional information. Scientific Reports. 7(1). 15819–15819. 16 indexed citations

13.

Castellano, Daniel, Carolina Rubio, Fernando López-Calderón, et al.. (2016). 8P Cdk4/6 inhibitor activity in metastatic bladder cancer cell lines is independently of RB1 status. Annals of Oncology. 27. ix3–ix3. 1 indexed citations

14.

Castellano, Daniel, Carolina Rubio, Fernando López-Calderón, et al.. (2016). RB-independent activity of Cdk4/6 in bladder cancer.. Journal of Clinical Oncology. 34(15_suppl). e16011–e16011. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact